Ampio Pharma (AMPE) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 45 101 sessions, May 6, 2025 to May 8, 2026
- Largest daily move
- +12207.7% close of May 7, 2026
- 1-year change
- +6681.5% closing prices, May 6, 2025 to May 8, 2026
Company Description
Ampio Pharma (OTC Link: AMPE) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $3.1K.
AMPE has gained 6681.5% over the past year. The last closing price was $0.1831.
For FY2023, Ampio Pharma reported net income of -$8.6M and diluted earnings per share of -$10.66.
This page collects what Stock Titan holds for AMPE, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Ampio Pharma (AMPE) closed at $0.1831 on May 8, 2026. Over the past 12 months, the price has gained 6681.5%.
AMPE Metrics & Rankings
Price returns through May 8, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Ampio Pharma has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include conferences, clinical trial, stock split, dividends. View all AMPE news →
SEC Filings
Financial Highlights
net income was -$8.6M. Diluted earnings per share stood at -$10.66. The company generated -$8.6M in operating cash flow. With a current ratio of 2.41, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Ampio Pharma (AMPE) currently stands at 25 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Ampio Pharma (AMPE) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
AMPE Company Profile & Sector Positioning
Ampio Pharma (AMPE) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing AMPE often look at related companies in the same sector, including BETTER THERAPEUTICS INC (BTTX), Gritstone Bio Inc (GRTSQ), Novaccess Global Inc (XSNX), Statera Biopharma Inc (STAB), and Renovacare (RCAR). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate AMPE's relative position within its industry.